Medtronic (MDT) Receives a Hold from Morgan Stanley
Morgan Stanley analyst David Lewis maintained a Hold rating on Medtronic (MDT) today and set a price target of $111. The company’s shares closed last Monday at $106.91, close to its 52-week high of $109.70.
According to TipRanks.com, Lewis is a 5-star analyst with an average return of 9.2% and a 70.5% success rate. Lewis covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Zimmer Biomet Holdings, and TransMedics Group Inc.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Medtronic with a $115.27 average price target, representing a 7.8% upside. In a report released today, Northland Securities also assigned a Hold rating to the stock with a $100 price target.
See today’s analyst top recommended stocks >>
Medtronic’s market cap is currently $143.4B and has a P/E ratio of 31.26. The company has a Price to Book ratio of 2.86.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.